Survival RatePancreatic NeoplasmsDisease-Free SurvivalSurvival AnalysisPrognosisTreatment OutcomeNeoplasm StagingRetrospective StudiesAntineoplastic Combined Chemotherapy ProtocolsKaplan-Meier EstimateCombined Modality TherapyNeoplasm Recurrence, LocalFollow-Up StudiesAdenocarcinomaCarcinoma, Pancreatic DuctalCell SurvivalDeoxycytidineChemotherapy, AdjuvantTumor Markers, BiologicalAntineoplastic AgentsNeoplasm MetastasisLung NeoplasmsCell Line, TumorTime FactorsLiver NeoplasmsProportional Hazards ModelsFluorouracilBreast NeoplasmsCisplatinMultivariate AnalysisNeoplasm InvasivenessAntimetabolites, AntineoplasticRadiotherapy, AdjuvantDisease ProgressionCarcinoma, Squamous CellGene Expression Regulation, NeoplasticLymphatic MetastasisVincristineRadiotherapy DosageStomach NeoplasmsSurvivalProspective StudiesCyclophosphamideImmunohistochemistryCarcinomaRisk FactorsDrug Administration ScheduleDoxorubicinCarcinoma, Non-Small-Cell LungChemoradiotherapyCarcinoma, HepatocellularOvarian NeoplasmsRemission InductionDose FractionationMice, NudeColorectal NeoplasmsNeoadjuvant TherapyPrednisoneRecurrenceSalvage TherapyEsophageal NeoplasmsRadiotherapyRisk AssessmentAge FactorsEtoposideTumor BurdenDrug Resistance, NeoplasmEarly Detection of CancerProstatic NeoplasmsCohort StudiesPredictive Value of TestsHepatectomyReverse Transcriptase Polymerase Chain ReactionCell ProliferationCA-19-9 AntigenBone NeoplasmsLymph Node ExcisionHead and Neck NeoplasmsOrganoplatinum CompoundsGraft SurvivalApoptosisBrain NeoplasmsXenograft Model Antitumor AssaysRectal NeoplasmsActuarial AnalysisNasopharyngeal NeoplasmsColonic NeoplasmsNeoplasm GradingPaclitaxelSarcomaRegistriesLeucovorinVinblastineNeoplasm ProteinsMethotrexateAntibodies, Monoclonal, HumanizedBrachytherapyNeoplasmsAntibodies, MonoclonalTaxoids